With respect to chronic GvHD in the human setting, a retrospective analysis of over 50 Japanese bone marrow transplant recipients receiving M‐CSF at or early after transplantation showed a lower risk to develop this complication (Kimura et al, 2012). The gene discussed is CSF1; the disease is chronic graft versus host disease.